Zometa
information and resources from the National Cancer Institute
NCI Thesaurus | Zometa
(Other name for: zoledronate)NCI Thesaurus | Zometa
(Other name for: zoledronate)
zoledronate
the treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors, in conjunction with standard antineoplastic therapy. Prostate cancer should have progressed after treatment with at least one hormonal therapy
Novartis Feb 22 2002
|
|
|
|
news articles
EBCC: Zometa with Femara Sooner Better Than Later in Keeping Bone Mar 23, 2006
MedPage Today, NICE, France, March 23 - Upfront treatment with Zometa (zoledronic acid) was significantly better than delayed Zometa at preserving bone mineral density in ...
New Data Support Bondronat's Superior Renal Safety Profile Against ... Mar 24, 2006
DG News Although Bondronat is not currently licensed for use in multiple myeloma, the audit results add to evidence from previous studies which indicate that Bondronat ...
New Data Show Zometa Increased Bone Mineral Density in Breast ... Mar 22, 2006
PharmaLive.com (press release), EAST HANOVER, NJ, March 22, 2006 - Zometa® (zoledronic acid) Injection infused twice per year significantly increased bone mineral density (BMD) in ...
Enrollment Complete in First Large-scale Trial to Evaluate if ... Mar 22, 2006
PharmaLive.com (press release), ...today that enrollment is complete eight months early in the first large-scale trial to determine the impact of adjuvant treatment with Zometa® (zoledronic acid ...
Early Use of Zoledronic Acid Prevents Letrozole-Related Bone Loss Mar 24, 2006
Medscape (subscription) March 24, 2006 (Nice, France) — Women who receive zoledronic acid (Zometa) at the initiation of breast cancer treatment with letrozole (Femara) have less ...
Oral Ibandronate and IV May Be Equally Efficacious in Treating ... Mar 27, 2006
DG News ...with metastatic bone disease due to breast cancer may respond equally well to oral ibandronate (Boniva) as they do to IV zoledronic acid (Zometa), according to ...
ZO-FAST Trial Shows Early Use of Zoledronic Acid Prevents Bone ... Mar 22, 2006
DG News NICE, FRANCE -- March 22, 2006 -- Women with estrogen receptor-positive breast cancer have less bone loss if they start zoledronic acid (Zometa) therapy early ...
Examine How Bisphosphonates is Used in the Treatment of Bone ... Mar 20, 2006
Genetic Engineering News, ...-- Intravenous (IV) treatment with bisphosphonates such as pamidronate (Novartis's Aredia) and zoledronic acid (Novartis's Zometa), in conjunction with ...
Randomized Trial Shows Ganite(R) Effective When Compared with a ... Mar 2, 2006
PR Newswire (press release), While bisphosphonates such as Aredia and Zometa(R) (zoledronate; Novartis, Inc.) are the most widely prescribed drugs for cancer-related bone loss, this trial ...
Further Evidence that Zometa® Reduces Bone Loss in Prostate ... Dec 6, 2005
Cancer Consultants (press release), According to a recent article published in Urology, further evidence indicates that treatment with Zometa (zoledronic acid) for one year prevents bone loss in ...
Further Evidence that Zometa® Reduces Bone Loss Associated with ... Dec 9, 2005
Cancer Consultants (press release), A multicenter trial has confirmed that Zometa (zoledronic acid) given for one year prevents bone loss in patients with metastatic prostate cancer who are ...
Switching Bisphosphonates Improves Pain Control in Breast Cancer ... Dec 14, 2005
Cancer Consultants (press release), They were switched to Zometa® (zoledronic acid). ... Eight weeks after changing to Zometa, improvements in pain control were noted by roughly 42% of patients. ...
Patients with Breast Cancer Bone Metastasis Failing Clodronate or ... Dec 16, 2005
Cancer Consultants (press release), Researchers from Toronto, Canada, recently reported that the administration of Zometa (zoledronic acid) significantly improved pain control in women with ...
Novartis Abandons Development of Cholesterol Drug (Update2) Dec 16, 2005
Bloomberg The company has introduced 14 products in the US since 2000, more than any rival of comparable size, with only cancer medicines Zometa and Gleevec bringing in ...
Ruffled feathers Dec 18, 2005
Ocala.com, Dr. Gary Butcher, left, and Ana Zometa, a biologist at UF, demonstrates how gloves are used in HEPA-filtered isolators when doing research on chickens. ...
Hope lives for cancer patients Dec 18, 2005
Birmingham News, I get monthly infusions of a drug called Zometa to strengthen my bones, which looked almost moth-eaten from the cancer lesions. ...
Long-Term Use of Bisphosphonates and Osteonecrosis of the Jaw ... Nov 30, 2005
Cancer Consultants (press release), Zometa® (zoledronic acid) and Aredia® (pamidronate) are two potent bisphosphonates that are approved for use in specific subsets of cancer patients. ...
Risk Factors for Osteonecrosis of the Jaw from Bisphosphonates ... Dec 2, 2005
Cancer Consultants (press release), The original reports involved the use of Zometa® (zoledronic acid), but cases have now been reported after Aredia® (pamidronate). ...
Novartis Abandons Development of Cholesterol Drug (Update1) Dec 15, 2005
Bloomberg While Novartis has introduced 14 products in the US since 2000, more than any rival of comparable size, only cancer medicines Zometa and Gleevec bring in more ...
Novartis Abandons Development of Cholesterol Drug (Update4) Dec 16, 2005
Bloomberg Novartis has introduced 14 products in the US since 2000, more than any rival of comparable size, but only cancer medicines Zometa and Gleevec generated more ...
Cytogen's QUADRAMET(R) Demonstrates Broad Anticancer Activity in ... Dec 12, 2005
PR Newswire (press release), QUADRAMET is also currently being evaluated in multiple myeloma patients in a Phase I combination trial with zoledronic acid (Zometa(R), Novartis AG). ...
Novartis to pay Astex to $520 m for drug rights Dec 6, 2005
Financial Express, Novartis, Europe’s second-largest drugmaker by market value, already sells oncology drugs including Gleevec and Zometa, both of which brought in more than $1 ...
Novartis to pay up to $520M for potential cancer therapies Dec 8, 2005
NorthJersey.com, Novartis already sells two widely used oncology drugs: Gleevec for treating leukemia and Zometa for treating bone metastases, each of which brought in more ...
Cancer patient fights to make 60 Dec 1, 2005
DesMoinesRegister.com, ...from dividing. On alternating Fridays, she also receives Taxotere, a chemotherapy, and Zometa, a bone-strengthener. Occasionally ...
Pfizer's Troubles Pull Down Drugmakers Nov 21, 2005
Chemical & Engineering News ...revenues from patented pharmaceuticals rose 11%, thanks in part to a 23% increase in sales of oncology drugs like Diovan, Gleevec, Lotrel, Femara, and Zometa. ...
|
|
